Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatWoundWistar albinoEither sexn = Six rats per group in four groups (24 in total)Topical5% and 10% weight for weight extract ointment (5 or 10 g ex…Starting on the day of wounding
Model: Full-thickness dorsal excision wound of 210 to 240 square millimetres and 1 to 2 mm depth created under ketamine anaesthesia (50 mg/kg intraperitoneally) and left undressed
Topical 5% and 10% extract ointments produced significantly greater wound contraction than both ointment base and nitrofurazone from day 6 onwards, reaching 99.30% and 99.13% contraction with complete healing by day 16.
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.